申请人:Pfizer Inc
公开号:US06605610B1
公开(公告)日:2003-08-12
Compounds of the formula
and their pharmaceutically acceptable salts, wherein R1, R2, and R3 are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.
该公式化合物及其药学上可接受的盐,其中R1、R2和R3的定义如本文所述;用于合成此类化合物的中间体,含有此类化合物的药物组合物;以及使用此类化合物治疗神经和心理障碍的方法。